Global Measurable Residual Disease Testing Supply, Demand and Key Producers, 2023-2029

Global Measurable Residual Disease Testing Supply, Demand and Key Producers, 2023-2029

The global Measurable Residual Disease Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Measurable residual disease (also known as “minimal residual disease”) refers to the number of cancer cells that remain during and after cancer treatment. Complete remission (less than 5% blasts in bone marrow) by morphologic assessment is not enough to accurately depict remaining malignant cells.

This report studies the global Measurable Residual Disease Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Measurable Residual Disease Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Measurable Residual Disease Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Measurable Residual Disease Testing total market, 2018-2029, (USD Million)

Global Measurable Residual Disease Testing total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Measurable Residual Disease Testing total market, key domestic companies and share, (USD Million)

Global Measurable Residual Disease Testing revenue by player and market share 2018-2023, (USD Million)

Global Measurable Residual Disease Testing total market by Type, CAGR, 2018-2029, (USD Million)

Global Measurable Residual Disease Testing total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Measurable Residual Disease Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adaptive Biotechnologies Corporation, ArcherDX, Inc. (Invitae Corporation), Asuragen, Arup Laboratories, Bio-Rad Laboratories, Cergentis B.V., F. Hoffmann- La Roche Ltd, Guardant Health and ICON plc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Measurable Residual Disease Testing market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Measurable Residual Disease Testing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Measurable Residual Disease Testing Market, Segmentation by Type
Flow Cytometry
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Other

Global Measurable Residual Disease Testing Market, Segmentation by Application
Hematological Malignancies
Leukemia
Lymphoma
Solid Tumors
Other

Companies Profiled:
Adaptive Biotechnologies Corporation
ArcherDX, Inc. (Invitae Corporation)
Asuragen
Arup Laboratories
Bio-Rad Laboratories
Cergentis B.V.
F. Hoffmann- La Roche Ltd
Guardant Health
ICON plc
Invivoscribe
Laboratory Corporation of America Holdings
Mission Bio
Natera, Inc.
NeoGenomics Laboratories
Opko Health
Quest Diagnostics Incorporated
Sysmex Corporation
Genetron Health

Key Questions Answered

1. How big is the global Measurable Residual Disease Testing market?

2. What is the demand of the global Measurable Residual Disease Testing market?

3. What is the year over year growth of the global Measurable Residual Disease Testing market?

4. What is the total value of the global Measurable Residual Disease Testing market?

5. Who are the major players in the global Measurable Residual Disease Testing market?

6. What are the growth factors driving the market demand?